FDA official logo
GSRS logo
PFDA official logo

ADALIMUMAB

  • UNII: FYS6T7F842
  • Preferred Substance Name: ADALIMUMAB

  • 331731-18-1
  • ABP-501
  • ABRILADA
  • ADALIMUMAB (GENETICAL RECOMBINATION)
  • ADALIMUMAB (GENETICAL RECOMBINATION) [JAN]
  • ADALIMUMAB (HUMIRA)
  • ADALIMUMAB [EMA EPAR]
  • ADALIMUMAB [HSDB]
  • ADALIMUMAB [INN]
  • ADALIMUMAB [JAN]
  • ADALIMUMAB [MART.]
  • ADALIMUMAB [MI]
  • ADALIMUMAB [PURPLE BOOK CDER]
  • ADALIMUMAB [USAN]
  • ADALIMUMAB [VANDF]
  • ADALIMUMAB [WHO-DD]
  • ADALIMUMAB BETA
  • ADALIMUMAB BETA [INN]
  • ADALIMUMAB BIOSIMILAR (ALVOTECH)
  • ADALIMUMAB BIOSIMILAR (AVT02)
  • ADALIMUMAB BIOSIMILAR (CELLTRION)
  • ADALIMUMAB BIOSIMILAR (CT-P17)
  • ADALIMUMAB BIOSIMILAR (FKB-327)
  • ADALIMUMAB BIOSIMILAR (SAMSUNG BIOEPIS)
  • ADALIMUMAB BIOSIMILAR (ZRC-3197)
  • ADALIMUMAB, LICENSE HOLDER UNSPECIFIED
  • ADALIMUMAB-ADAZ
  • ADALIMUMAB-ADAZ [PURPLE BOOK CDER]
  • ADALIMUMAB-ADAZ [WHO-DD]
  • ADALIMUMAB-ADBM
  • ADALIMUMAB-ADBM [PURPLE BOOK CDER]
  • ADALIMUMAB-ADBM [WHO-DD]
  • ADALIMUMAB-AFZB
  • ADALIMUMAB-AFZB [WHO-DD]
  • ADALIMUMAB-ATTO
  • ADALIMUMAB-ATTO [PURPLE BOOK CDER]
  • ADALIMUMAB-ATTO [WHO-DD]
  • ADALIMUMAB-BWWD
  • ADALIMUMAB-BWWD [WHO-DD]
  • ADALIMUMAB-FKJP
  • ADALIMUMAB-FKJP [WHO-DD]
  • AMJEVITA
  • AVT02
  • AVT-02
  • BCD-057
  • BI695501
  • BI-695501
  • BI-695501 [WHO-DD]
  • CHS-1420
  • CT-P17
  • CYLTEZO
  • D2E7
  • D3E7
  • EXEMPTIA
  • FKB327
  • FKB-327
  • GP2017
  • GP-2017
  • HADLIMA
  • HULIO
  • HUMIRA
  • HYRIMOZ
  • IMMUNOGLOBULIN G1, ANTI-(HUMAN TUMOR NECROSIS FACTOR) (HUMAN MONOCLONAL D2E7 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL D2E7 LIGHT CHAIN, DIMER
  • IMMUNOGLOBULIN G1, ANTI-(HUMAN TUMOR NECROSIS FACTOR) (HUMAN MONOCLONAL D2E7 HEAVY CHAIN), DISULPHIDE WITH HUMAN MONOCLONAL D2E7 LIGHT CHAIN, DIMER
  • LBAL
  • LU200134
  • LU-200134
  • M923
  • M-923
  • ONS-3010
  • SB5
  • SB-5
  • TRUDEXA
  • ZRC3197
  • ZRC-3197

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.